Inactive Instrument

Press Releases Myovant Sciences Ltd.

Equities

MYOV

BMG637AM1024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

MYOVANT SCIENCES LTD. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)	23-03-10	AQ
MYOVANT SCIENCES LTD. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-03-01	AQ
LifeSci Index Partners	23-02-28	AQ
Myovant Sciences: Fiscal Q3 Earnings Snapshot	23-01-26	AQ
MYOVANT SCIENCES LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-01-26	AQ
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022	23-01-26	GL
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV	23-01-25	BU
MYOVANT SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV	23-01-11	PR
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08	22-11-16	GL
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08	22-11-16	AQ
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources	22-11-16	GL
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources	22-11-16	AQ
Urovant Sciences Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season	22-11-15	AQ
Myovant Sciences: Fiscal Q2 Earnings Snapshot	22-10-26	AQ
MYOVANT SCIENCES LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-10-26	AQ
Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022	22-10-26	GL
Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022	22-10-26	GL
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV	22-10-25	BU
Myovant Sciences Cancels Second Quarter Earnings Conference Call	22-10-24	GL
Vaxcyte, Myovant rise; Dorman, Shift4 Payments fall	22-10-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Myovant Sciences Ltd.

Equities

MYOV

BMG637AM1024

Press Releases

Filters